Cephalon
Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the
Business Model:
Revenue: $0
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Cephalon Information
Cephalon was acquired by
Teva Pharmaceutical Industries.
The acquisition happend on 2011-05-02.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Malvern
State: Pennsylvania
Zip:
Country: United States
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world&s;s fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&a;P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries.
Contact Phone:
Contact Email:
Cephalon went public on 11/20/2007 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/20/2007
Ticker Symbol:
CEPH
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2007 | SymBio Pharmaceuticals | Venture Round | 0 |
| 4/2009 | SymBio Pharmaceuticals | Venture Round | 0 |
| 2/2003 | TransTech Pharma | Venture Round | 0 |
| 4/2008 | SymBio Pharmaceuticals | Corporate Round | 0 |
| 2/2011 | SymBio Pharmaceuticals | Series E | 0 |
| 12/2009 | SymBio Pharmaceuticals | Venture Round | 0 |
| 2/2011 | SymBio Pharmaceuticals | Series E | 0 |
| 12/2009 | SymBio Pharmaceuticals | Venture Round | 0 |
| 4/2009 | SymBio Pharmaceuticals | Venture Round | 0 |
| 4/2008 | SymBio Pharmaceuticals | Corporate Round | 0 |
| 11/2007 | SymBio Pharmaceuticals | Venture Round | 0 |
| 2/2003 | TransTech Pharma | Venture Round | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 3/2011 | ChemGenex Pharmaceuticals | |
| 3/2011 | Gemin X Pharmaceuticals | |
| 2/2010 | Ception Therapeutics | |
| 2/2010 | Mepha Pharma | |
| 8/2009 | Arana Therapeutics | |
| 5/2005 | Salmedix |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
